Scholarlink

<p>Rhynchophylline (Rhy), a bioactive alkaloid extracted from <i>Uncaria</i> species (<i>Uncaria rhynchophylla and Uncaria tomentosa</i>), has demonstrated therapeutic potential in neurodegenerative and cardiovascular diseases due to its diverse pharmacological effects. However, its role in the development or treatment of atherosclerosis has not yet been studied. In this study, we evaluated the anti-atherosclerotic effects of Rhy using both in vivo and in vitro models. In high-fat diet-fed New Zealand White rabbits, Rhy treatment significantly reduced aortic plaque progression, improved vascular histology, and decreased serum cholesterol levels. In THP-1 macrophages, Rhy inhibited ox-LDL uptake and subsequent foam cell formation by lowering scavenger receptor expression. In endothelial cells, it decreased the expression of adhesion molecules, thereby reducing monocyte adhesion and transendothelial migration. Mechanistically, Rhy suppressed the activation of MAPK and NF-κB signaling pathways, contributing to its anti-inflammatory and antioxidant effects. Overall, these results demonstrate that Rhy offers multi-targeted protective effects against atherosclerosis and could be a promising candidate for its prevention and treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Rhynchophylline alleviates early atherosclerosis by attenuating oxidized low-density lipoprotein-induced foam cell formation and endothelial dysfunction

  • 期刊论文

  • 发表日期：

    2025年10月24日

查看全文
  • Jeeva Prasannan,
  • Archana Sobha,
  • Abdul Jaleel,
  • Vinod Vikraman Thambi Mohanakumari,
  • Surya Ramachandran

摘要

Rhynchophylline (Rhy), a bioactive alkaloid extracted from Uncaria species (Uncaria rhynchophylla and Uncaria tomentosa), has demonstrated therapeutic potential in neurodegenerative and cardiovascular diseases due to its diverse pharmacological effects. However, its role in the development or treatment of atherosclerosis has not yet been studied. In this study, we evaluated the anti-atherosclerotic effects of Rhy using both in vivo and in vitro models. In high-fat diet-fed New Zealand White rabbits, Rhy treatment significantly reduced aortic plaque progression, improved vascular histology, and decreased serum cholesterol levels. In THP-1 macrophages, Rhy inhibited ox-LDL uptake and subsequent foam cell formation by lowering scavenger receptor expression. In endothelial cells, it decreased the expression of adhesion molecules, thereby reducing monocyte adhesion and transendothelial migration. Mechanistically, Rhy suppressed the activation of MAPK and NF-κB signaling pathways, contributing to its anti-inflammatory and antioxidant effects. Overall, these results demonstrate that Rhy offers multi-targeted protective effects against atherosclerosis and could be a promising candidate for its prevention and treatment.